Skip to main content
. Author manuscript; available in PMC: 2018 Jun 27.
Published in final edited form as: Curr Rheumatol Rep. 2018 Mar 26;20(4):21. doi: 10.1007/s11926-018-0732-6

Fig. 1.

Fig. 1

Association of creatine kinase (CK) levels with anti-HMGCR titers (a and b) and examples of the evolution of strength and CK over time in a patient with immune-mediated necrotizing myopathy (c and d). Expressing the CK levels in a logarithmic scale (a and c) correlates better with the activity of the disease (autoantibody levels and strength) than when using it in a linear scale (b and d)